Illumina, Inc.
ILMN
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $33.0B
$218.22
▼ -1.55%
P/E
40.64
Mkt Cap
$33.0B
52-Wk Range
$88.00–$231.81
52-Week Range
$88.00 - $231.81
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 122.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Technological leadership in genetic sequencing
- Comprehensive genomic solution ecosystem
- Strong intellectual property portfolio
- Global market penetration
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Precision medicine expansion
Value
Significant premium - growth priced in
Momentum
Hot
+38.1% over 3m
Quality
Excellent
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying ILMN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
JUL 30, 2026
Reported EPS of $1.31 vs $1.23 consensus (+6.5% surprise). Revenue of $1.2B vs $1.1B expected (+2.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+6.5%
Revenue trend · last 8Q
—
-2%
-3%
-5%
+0%
+5%
+5%
+10%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$1.1B
$1.1B
$1.0B
$1.1B
$1.1B
$1.2B
$1.1B
$1.2B
Margins · last 8Q
Gross
66.4%
Operating
21.1%
Profit
-11.6%
Wall Street consensus
11 analysts · 36% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
36%
Hold
45%
Sell
18%
Median Price Target
$200.00
▼ -8.3% vs $218.22
Latest: Deutsche Bank · Aug 5, 2026
1 analyst covering
vs Industry
How ILMN stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related